Science and Discovery
Section

Health & Medicine

The latest research and breakthroughs in medical science, from new treatments to public health.

Editorial illustration for New Drug HRO761 Offers Targeted Hope for MSI Cancers, Including ICI-Resistant Cases
Health & Medicine

New Drug HRO761 Offers Targeted Hope for MSI Cancers, Including ICI-Resistant Cases

HRO761, a novel drug targeting the Werner syndrome helicase (WRN), shows promise for MSI cancers, including those resistant to immune checkpoint inhibitors. Currently in Phase 1 trials, it exploits synthetic lethality to selectively inhibit tumor growth.

Marcus Cole· Sep 29· 5 min read
How to Organize Your Medical History: A Practical Guide to Using a Health Journal App

How to Organize Your Medical History: A Practical Guide to Using a Health Journal App

Sponsored by My Journal Med · Oct 9
Why SmartSaveMeds is Essential as Specialty Drug Spending Skyrockets in 2026 (Expert Analysis)

Why SmartSaveMeds is Essential as Specialty Drug Spending Skyrockets in 2026 (Expert Analysis)

Sponsored by SmartSaveMeds · Oct 8
Keeping Your Regular Doctor Involved During Hospice With Dynamic in-Home Care

Keeping Your Regular Doctor Involved During Hospice With Dynamic in-Home Care

Sponsored by Dynamic In-Home Care · Oct 7
Use Bio-Emotive Framework’s Unpacking Body Pain Form to Examine Emotional Tension

Use Bio-Emotive Framework’s Unpacking Body Pain Form to Examine Emotional Tension

Sponsored by Bio-Emotive Framework · Oct 6
From Start to Finish: How Imaging Orders Direct Simplifies Getting an MRI Scan

From Start to Finish: How Imaging Orders Direct Simplifies Getting an MRI Scan

Obtaining an MRI can feel like a complex journey, often involving long waits for primary care appointments just to get a referral. As demand for advanced imaging grows—with the MRI systems segment expected to lead diagno…

Sponsored by Imaging Orders Direct· Oct 6· 5 min
Editorial illustration for Novel Kidney Drug INM004 Enters Final Trial for Life-Threatening HUS

Novel Kidney Drug INM004 Enters Final Trial for Life-Threatening HUS

Argentine biotech Inmunova has initiated a Phase 3 clinical trial for INM004, a novel drug designed to neutralize the Shiga toxin responsible for Haemolytic Uraemic Syndrome (HUS). This investigational therapy aims to be the first specific treatment for the severe kidney disorder, potentially preventing irreversible organ damage.

Marcus Cole· Oct 4· 4 min